AR065079A1 - Procesos para la preparacion de n-(1-acilpiperidin-4-il)-n'-(adamant-1-il)urea e intermdediarios de dichos procesos. - Google Patents
Procesos para la preparacion de n-(1-acilpiperidin-4-il)-n'-(adamant-1-il)urea e intermdediarios de dichos procesos.Info
- Publication number
- AR065079A1 AR065079A1 ARP080100360A ARP080100360A AR065079A1 AR 065079 A1 AR065079 A1 AR 065079A1 AR P080100360 A ARP080100360 A AR P080100360A AR P080100360 A ARP080100360 A AR P080100360A AR 065079 A1 AR065079 A1 AR 065079A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- formula
- compound
- alkyl
- heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Se describen procesos para la síntesis de compuestos de urea sustituidos con piperidinilo. Se proveen también intermediarios preparados durante esta síntesis. Reivindicacion 1: Un proceso para la preparacion de compuestos de urea de la formula (1), en donde R1 se selecciona del grupo que consiste en alquilo, alquilo sustituido, arilo, arilo sustituido, heteroarilo, heteroarilo sustituido, cicloalquilo, cicloalquilo sustituido, heterocíclico y heterocíclico sustituido, y m es cero, 1 o 2; caracterizado porque comprende: a) poner en contacto al menos una cantidad equimolar de un compuesto de la formula (2) R1C(O)X en donde X es -OH, halo u -OC(O)R, en donde R es alquilo, alquilo sustituido, arilo, arilo sustituido, heteroarilo, heteroarilo sustituido, cicloalquilo, cicloalquilo sustituido, heterocíclico, o heterocíclico sustituido, con un compuesto de la formula (3), en un solvente inerte en condiciones que proveen un compuesto de la formula (4), b) poner en contacto el compuesto de la formula (4) producido en a) anterior con adamantilamina en presencia de un solvente inerte y un reactivo que convierte el grupo H2NC(O)- amido del compuesto de la formula (4) en un grupo isocianato en condiciones en las cuales el grupo isocianato reacciona con la amina de dicho grupo adamantilamina para formar el compuesto de la formula (1). Reivindicacion 14: Un compuesto de la formula (8a) o (8b) caracterizado porque es -CO-W, -SO2-W, o W, en donde W es alquilo, alquilo sustituido, arilo, arilo sustituido, heteroarilo, heteroarilo sustituido, cicloalquilo, cicloalquilo sustituido, heterocíclico, o heterocíclico sustituido, con la condicion de que en la formula (8a) R7 no es -COCF3, -CH2-C6H5, o formula (11). Reivindicacion 15: Un compuesto de la formula (9) en donde R8 es alquilo C1-6. Reivindicacion 16: Un compuesto de la formula (10), caracterizado porque R9 es alquilo C1-6.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88711407P | 2007-01-29 | 2007-01-29 | |
| US97217707P | 2007-09-13 | 2007-09-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR065079A1 true AR065079A1 (es) | 2009-05-13 |
Family
ID=39493517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080100360A AR065079A1 (es) | 2007-01-29 | 2008-01-29 | Procesos para la preparacion de n-(1-acilpiperidin-4-il)-n'-(adamant-1-il)urea e intermdediarios de dichos procesos. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20080207908A1 (es) |
| EP (1) | EP2125729A1 (es) |
| JP (1) | JP2010516785A (es) |
| KR (1) | KR20090107045A (es) |
| CN (1) | CN101663273A (es) |
| AR (1) | AR065079A1 (es) |
| AU (1) | AU2008210723A1 (es) |
| BR (1) | BRPI0807125A2 (es) |
| CA (1) | CA2675448A1 (es) |
| EA (1) | EA200901063A1 (es) |
| EC (1) | ECSP099599A (es) |
| IL (1) | IL199654A0 (es) |
| MX (1) | MX2009008093A (es) |
| TW (1) | TW200838851A (es) |
| WO (1) | WO2008094862A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090197916A1 (en) * | 2007-01-29 | 2009-08-06 | Arete Therapeutics, Inc | Soluble epoxide hydrolase inhibitors for treatment of metabolic syndrome and related disorders |
| CN115109841B (zh) * | 2022-06-23 | 2025-11-04 | 苏州拉索生物芯片科技有限公司 | 一种芯片微球氨基封闭方法及应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9216298D0 (en) * | 1991-08-15 | 1992-09-16 | Ici Plc | Piperidine derivatives |
| US7081454B2 (en) * | 2001-03-28 | 2006-07-25 | Bristol-Myers Squibb Co. | Tyrosine kinase inhibitors |
| DE602004014937D1 (de) * | 2003-08-01 | 2008-08-21 | Chugai Pharmaceutical Co Ltd | Piperidin-verbindungen als malonyl-coa decarboxylase-hemmer |
| AR059826A1 (es) * | 2006-03-13 | 2008-04-30 | Univ California | Inhibidores de urea conformacionalmente restringidos de epoxido hidrolasa soluble |
-
2008
- 2008-01-28 EP EP08728391A patent/EP2125729A1/en not_active Withdrawn
- 2008-01-28 AU AU2008210723A patent/AU2008210723A1/en not_active Abandoned
- 2008-01-28 US US12/021,090 patent/US20080207908A1/en not_active Abandoned
- 2008-01-28 EA EA200901063A patent/EA200901063A1/ru unknown
- 2008-01-28 CN CN200880003369A patent/CN101663273A/zh active Pending
- 2008-01-28 TW TW097103103A patent/TW200838851A/zh unknown
- 2008-01-28 WO PCT/US2008/052196 patent/WO2008094862A1/en not_active Ceased
- 2008-01-28 CA CA002675448A patent/CA2675448A1/en not_active Abandoned
- 2008-01-28 KR KR1020097015884A patent/KR20090107045A/ko not_active Withdrawn
- 2008-01-28 MX MX2009008093A patent/MX2009008093A/es not_active Application Discontinuation
- 2008-01-28 BR BRPI0807125-0A2A patent/BRPI0807125A2/pt not_active IP Right Cessation
- 2008-01-28 JP JP2009547453A patent/JP2010516785A/ja not_active Withdrawn
- 2008-01-29 AR ARP080100360A patent/AR065079A1/es unknown
-
2009
- 2009-07-02 IL IL199654A patent/IL199654A0/en unknown
- 2009-08-27 EC EC2009009599A patent/ECSP099599A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20080207908A1 (en) | 2008-08-28 |
| BRPI0807125A2 (pt) | 2014-04-08 |
| CA2675448A1 (en) | 2008-08-07 |
| TW200838851A (en) | 2008-10-01 |
| EP2125729A1 (en) | 2009-12-02 |
| EA200901063A1 (ru) | 2009-12-30 |
| WO2008094862A1 (en) | 2008-08-07 |
| JP2010516785A (ja) | 2010-05-20 |
| MX2009008093A (es) | 2009-08-12 |
| AU2008210723A1 (en) | 2008-08-07 |
| CN101663273A (zh) | 2010-03-03 |
| IL199654A0 (en) | 2010-04-15 |
| KR20090107045A (ko) | 2009-10-12 |
| ECSP099599A (es) | 2009-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1781683T3 (da) | Fremgangsmåde til fremstilling af 17-vinyl-triflater som halvfabrikata | |
| BRPI0516911A (pt) | método para a preparação de um composto e composto de anilina | |
| AR039150A1 (es) | Piridinoilpiperidinas como agonistas de 5-ht1f | |
| NO20091242L (no) | Fremgangsmate for fremstilling av biarylsubstituerte 4-aminosmorsyre eller derivater derav og deres anvendelse ved fremstilling av NEP-inhibitorer | |
| AR059201A1 (es) | Compuestos citotoxicos derivados de tomaimicina | |
| SG164384A1 (en) | Novel heterocyclic compound or salt thereof and intermediate thereof | |
| AR054130A1 (es) | Procedimiento para la preparacion de 1-alquil-3-feniluracilos | |
| WO2008146871A1 (ja) | グルココルチコイド受容体結合活性を有する、スルホン酸エステル又はスルホン酸アミド構造を導入したフェニル基を置換基として有する新規１，２，３，４－テトラヒドロキノキサリン誘導体 | |
| MX2010003148A (es) | Procedimiento para la preparacion de diamidas de acido sulfonico. | |
| ATE472541T1 (de) | N-(1-alkyl-2-phenylethyl)carbonsäureamidderivat und deren verwendung als fungizide | |
| MX2023014235A (es) | Un proceso novedoso para la preparacion de diamidas antranilicas. | |
| ATE373643T1 (de) | Als fungizide geeignete 2- pyridinylcycloalkylcarbonsäureamidderivate | |
| EA200701470A1 (ru) | Способы получения производных 4-(фенокси-5-метилпиримидин-4-илокси)пиперидин-1-карбоновой кислоты и родственных соединений | |
| NO20076000L (no) | Aminosyrederivater | |
| TNSN07395A1 (en) | Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives | |
| DE602006008962D1 (de) | Verfahren zur herstellung von valsartan | |
| AR065079A1 (es) | Procesos para la preparacion de n-(1-acilpiperidin-4-il)-n'-(adamant-1-il)urea e intermdediarios de dichos procesos. | |
| BR0315112A (pt) | Sal de adição ácido, e, processo para a preparação de um composto | |
| ATE532516T1 (de) | Verfahren zur synthese von glyt-1-hemmern | |
| EA200870038A1 (ru) | Способ получения аминов | |
| EP1770084A4 (en) | PROCESS FOR PREPARING (Z) -1-PHENYL-1-DIETHYLAMINOCARBONYL-2-AMINOMETHYLCYCLOPROPANHYDROCHLORIDE | |
| AR047810A1 (es) | Proceso quimico | |
| AR070737A1 (es) | Proceso para la elaboracion de (fenilsulfanilfenil) piperidinas | |
| AR057451A1 (es) | Metodos para preparar derivados de acido glutamico | |
| AR051936A1 (es) | Proceso para la preparacion de pirazoles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |